Goldman Sachs’s VYNE Therapeutics VYNE Stock Holding History
Bought
Maintained
Sold
| Quarter | Market Value | Status | Shares |
Change in Stake | Trade Value | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2022
Q1 | – | Sell |
|
|||||
|
2021
Q4 | $118K | Buy |
|
|||||
|
2021
Q3 | $58K | Buy |
|
|||||
|
2021
Q2 | $141K | Sell |
|
|||||
|
2021
Q1 | $310K | Buy |
|
|||||
|
2020
Q4 | $278K | Buy |
|
|||||
|
2020
Q3 | $151K | Sell |
|
|||||
|
2020
Q2 | $177K | Buy |
|
|||||
|
2020
Q1 | $151K | Sell |
|
|||||
|
2019
Q4 | $266K | Buy |
|
|||||
|
2019
Q3 | $167K | Sell |
|
|||||
|
2019
Q2 | $238K | Buy |
|
|||||
|
2019
Q1 | $301K | Buy |
|
|||||
|
2018
Q4 | $148K | Buy |
|
|||||
|
2018
Q3 | $288K | Buy |
|
|||||
|
2018
Q2 | $118K | Buy |
|